Author Prokakis, Evangelos

1 to 10 of 10 Items
  • 2019 Journal Article | 
    ​ ​The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells​
    Schneider, D.; Chua, R. L; Molitor, N.; Hamdan, F. H; Rettenmeier, E. M; Prokakis, E. & Mishra, V. K et al.​ (2019) 
    Clinical Epigenetics11(1) art. 98​.​ DOI: https://doi.org/10.1186/s13148-019-0698-x 
    Details  DOI 
  • 2019 Journal Article | 
    ​ ​USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer​
    Kosinsky, R. L. ; Helms, M.; Zerche, M.; Wohn, L.; Dyas, A.; Prokakis, E. & Kazerouni, Z. B. et al.​ (2019) 
    Cell Death & Disease10(12).​ DOI: https://doi.org/10.1038/s41419-019-2141-9 
    Details  DOI 
  • 2020 Journal Article | 
    ​ ​The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis​
    Wegwitz, F. ; Prokakis, E.; Pejkovska, A.; Kosinsky, R. L. ; Glatzel, M.; Pantel, K. & Wikman, H. et al.​ (2020) 
    Cell Death & Disease11(10).​ DOI: https://doi.org/10.1038/s41419-020-03081-w 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response​
    Prokakis, E.; Dyas, A.; Grün, R.; Fritzsche, S.; Bedi, U.; Kazerouni, Z. B. & Kosinsky, R. L. et al.​ (2021) 
    Oncogene,.​ DOI: https://doi.org/10.1038/s41388-021-01814-5 
    Details  DOI 
  • 2021 Journal Article | Research Paper | 
    ​ ​Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments​
    Mieczkowska, I. K.; Pantelaiou-Prokaki, G.; Prokakis, E.; Schmidt, G. E.; Müller-Kirschbaum, L. C.; Werner, M. & Sen, M.  et al.​ (2021) 
    Cell Death & Disease12(12) art. 1118​.​ DOI: https://doi.org/10.1038/s41419-021-04407-y 
    Details  DOI 
  • 2021 Journal Article
    ​ ​Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas​
    Wang, X.; Kutschat, A. P.; Yamada, M.; Prokakis, E.; Böttcher, P.; Tanaka, K. & Doki, Y. et al.​ (2021) 
    Cell Death and Differentiation28(7) pp. 2207​-2220​.​ DOI: https://doi.org/10.1038/s41418-021-00751-w 
    Details  DOI 
  • 2022 Journal Article | Research Paper
    ​ ​HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer​
    Pantelaiou-Prokaki, G.; Mieczkowska, I.; Schmidt, G. E.; Fritzsche, S.; Prokakis, E.; Gallwas, J. & Wegwitz, F.​ (2022) 
    Clinical Epigenetics14(1) art. 7​.​ DOI: https://doi.org/10.1186/s13148-022-01228-4 
    Details  DOI 
  • 2023 Journal Article | 
    ​ ​RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer​
    Prokakis, E.; Jansari, S.; Boshnakovska, A.; Wiese, M.; Kusch, K.; Kramm, C. & Dullin, C. et al.​ (2023) 
    Cell Death & Disease14(9).​ DOI: https://doi.org/10.1038/s41419-023-06157-5 
    Details  DOI  PMID  PMC 
  • 2023 Journal Article | 
    ​ ​Basal‐like mammary carcinomas stimulate cancer stem cell properties through AXL‐signaling to induce chemotherapy resistance​
    Pantelaiou‐Prokaki, G.; Reinhardt, O.; Georges, N. S.; Agorku, D. J.; Hardt, O.; Prokakis, E. & Mieczkowska, I. K. et al.​ (2023) 
    International Journal of Cancer152(9) art. ijc.34429​.​ DOI: https://doi.org/10.1002/ijc.34429 
    Details  DOI 
  • 2024 Journal Article | 
    ​ ​USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration​
    Prokakis, E.; Bamahmoud, H.; Jansari, S.; Fritsche, L.; Dietz, A.; Boshnakovska, A. & Rehling, P. et al.​ (2024) 
    Cell Communication and Signaling22(1) art. 120​.​ DOI: https://doi.org/10.1186/s12964-023-01441-5 
    Details  DOI 

Researcher

Sort

issue date

ASC DESC

Items per Page